Placebo- Controlled Study to Evaluate the Safety and Immunogenicity of the RSV-F Vaccine in Elderly Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

1,599

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Respiratory Syncytial Virus (RSV)
Interventions
BIOLOGICAL

RSV-F Vaccine

BIOLOGICAL

Saline Placebo

Trial Locations (10)

30281

Clinical Research Atlanta, Stockbridge

37203

Clinical Research Associates, Nashville

44122

Rapid Medical Research, Cleveland

54401

Marshfield Clinical Research Foundation, Wausau

66219

Johnson County Clin-Trials, Lenexa

75234

Research Across America, Dallas

78229

Clinical Trials of Texas, San Antonio

84088

Advanced Clinical Research, West Jordan

96001

Nothern California Clinical Research, Redding

98101

Lisa Jackson, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novavax

INDUSTRY